Neurology Archives - Insights

Comprehensive autoimmune/ paraneoplastic evaluations are critical in identifying coexisting antibodies

Mayo Clinic Laboratories — Wed, 09 Sep 2026 13:00:00 +0000

Find out how our autoimmune/paraneoplastic encephalopathy evaluations can identify multiple antibodies and guide the search for occult cancer.

The post Comprehensive autoimmune/ paraneoplastic evaluations are critical in identifying coexisting antibodies appeared first on Insights.

UNC Health: Reducing redundant testing and achieving improved answers

Robin Huiras-Carlson — Tue, 08 Sep 2026 13:00:00 +0000

Collaborating with Mayo Clinic Laboratories, UNC Health streamlined neuroimmunology test ordering — eliminating outmoded testing and elevating diagnostic accuracy.

The post UNC Health: Reducing redundant testing and achieving improved answers appeared first on Insights.

Unlock the Full Potential of Research Data

Mayo Clinic Laboratories — Thu, 03 Sep 2026 13:00:00 +0000

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss advancement in Alzheimer’s testing and practical uses of artificial intelligence (AI) in healthcare. Later, Dr. Pritt welcomes Chris Garcia, M.D., Mayo Clinic Laboratories’ chief digital innovation officer, to explore the evolving role of data in research and development.

The post Unlock the Full Potential of Research Data appeared first on Insights.

Nerve biopsy testing

Robin Huiras-Carlson — Tue, 18 Aug 2026 13:00:00 +0000

Learn more about how Mayo Clinic’s Nerve Pathology Laboratory leverages decades of nerve pathology testing experience and unmatched clinical expertise to provide diagnostic clarity for rare and complex neuropathies.

The post Nerve biopsy testing appeared first on Insights.

PDE10A autoimmunity presents as hyperkinetic movement disorder triggered by ICI treatment

Mayo Clinic Laboratories — Wed, 12 Aug 2026 13:00:00 +0000

Find out how our suite of autoimmune movement disorder testing can help diagnose PDE10A autoimmunity in patients who present with hyperkinetic movement disorders.

The post PDE10A autoimmunity presents as hyperkinetic movement disorder triggered by ICI treatment appeared first on Insights.

Genome-wide methylation profiling brings new clarity to brain tumor diagnosis

jgilligan1 — Wed, 05 Aug 2026 13:00:00 +0000

Genome-wide methylation profiling is transforming the way clinicians approach brain tumor diagnosis. By analyzing epigenetic patterns across the genome, this advanced testing method provides a new level of precision, helping resolve ambiguous cases, reduce diagnostic variability, and support more confident clinical decision-making in complex CNS tumors.

The post Genome-wide methylation profiling brings new clarity to brain tumor diagnosis appeared first on Insights.

The Role of GFAP and Its Clinical Use Cases

MCL Education — Tue, 04 Aug 2026 10:00:00 +0000

Learn how GFAP testing is emerging as a biomarker to support diagnosis, monitoring, and prognosis in neurological diseases.

The post The Role of GFAP and Its Clinical Use Cases appeared first on Insights.

Muscle biopsy testing

Robin Huiras-Carlson — Tue, 21 Jul 2026 13:00:00 +0000

Discover how Mayo Clinic’s nationally recognized Muscle Pathology Laboratory provides unparalleled diagnostic accuracy for rare muscle diseases through decades of experience, specialized testing, and integrated clinical-pathological evaluation.

The post Muscle biopsy testing appeared first on Insights.

Living with ultra-rare epilepsy and chasing her dream: Giana Urse

Robin Huiras-Carlson — Mon, 20 Jul 2026 12:00:00 +0000

Supported by Mayo Clinic’s holistic, precision medicine approach, which included advanced genetic insights, access to an emerging therapy, and tailored treatment monitoring, Giana Urse gained the confidence and clarity she needed to pursue her dream of becoming a dog trainer.

The post Living with ultra-rare epilepsy and chasing her dream: Giana Urse appeared first on Insights.

Using CSF testing to confirm autoimmune GFAP meningoencephalomyelitis

Mayo Clinic Laboratories — Thu, 16 Jul 2026 13:00:00 +0000

Learn how our autoimmune/paraneoplastic evaluation for encephalopathy uses CSF testing to confirm an autoimmune GFAP meningoencephalomyelitis diagnosis.

The post Using CSF testing to confirm autoimmune GFAP meningoencephalomyelitis appeared first on Insights.